Nu Skin Enterprises, Inc. (NYSE:NUS), a global direct selling company, announced the appointment of Mark A. Zorko to its Board of Directors on Monday. The addition of Zorko expands the Board from eight to nine members and is effective immediately.
Zorko, whose experience includes roles in finance and governance across various industries, will also serve on the Audit Committee and the Nominating and Corporate Governance Committee. His compensation aligns with Nu Skin's non-employee director compensation program, prorated to 75% due to his mid-term appointment.
Nu Skin Enterprises confirmed that there are no related-person transactions between the company and Zorko, and his appointment is not based on any arrangement with other individuals. The company, headquartered in Provo, Utah, is known for its personal care products and dietary supplements.
In other recent news, Nu Skin Enterprises, a global beauty and wellness company, has declared a quarterly cash dividend of $0.06 per share. This payment is scheduled for September 11, 2024, targeting shareholders recorded as of August 30, 2024. The company's diverse portfolio comprises Nu Skin personal care, Pharmanex nutrition, and ageLOC anti-aging brands.
With over 40 years of scientific research under its belt, Nu Skin operates in nearly 50 markets globally. Additionally, Rhyz Inc., a strategic investment arm of Nu Skin Enterprises, is dedicated to promoting innovation in the beauty, wellness, and lifestyle sectors.
InvestingPro Insights
As Nu Skin Enterprises (NYSE:NUS) welcomes Mark A. Zorko to its Board of Directors, investors may find the following insights from InvestingPro valuable. The company's management has demonstrated confidence in its future by aggressively buying back shares, which is often seen as a bullish signal. Additionally, Nu Skin has a noteworthy track record of raising its dividend, doing so for 23 consecutive years, showcasing a commitment to returning value to shareholders. On the financial front, analysts are predicting net income growth for the year, which could signal a positive outlook for the company's profitability.
InvestingPro data highlights that Nu Skin has maintained impressive gross profit margins, a testament to its operational efficiency. However, it's important to note that some analysts have revised their earnings estimates downwards for the upcoming period. For investors interested in the company's financial health, InvestingPro Tips include that Nu Skin's liquid assets exceed its short-term obligations, providing a cushion for the company's operations. To explore further insights and get additional InvestingPro Tips on Nu Skin Enterprises, interested parties can visit: https://www.investing.com/pro/NUS.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.